These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2119086

  • 1. A simple plasma anticoagulant-exchange method to increase the recovery of factor VIII in therapeutic concentrates.
    Cumming AM, Wensley RT, Winkelman L, Lane RS.
    Vox Sang; 1990; 58(4):264-9. PubMed ID: 2119086
    [Abstract] [Full Text] [Related]

  • 2. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
    de Wit HJ, Scheer G, Muradin J, van der Does JA.
    Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
    [Abstract] [Full Text] [Related]

  • 3. Effect of citrate anticoagulants on factor VIII levels in plasma.
    Rock G, Tittley P, Fuller V.
    Transfusion; 1988; 28(3):248-52. PubMed ID: 3130694
    [Abstract] [Full Text] [Related]

  • 4. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates.
    Farrugia A, Douglas S, James J, Whyte G, Herrington R.
    Thromb Haemost; 1990 Nov 30; 64(3):374-8. PubMed ID: 2128967
    [Abstract] [Full Text] [Related]

  • 5. [Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
    Sunakawa M, Arai I, Okinami S.
    Nippon Ganka Gakkai Zasshi; 1986 Jun 30; 90(6):871-4. PubMed ID: 3751789
    [No Abstract] [Full Text] [Related]

  • 6. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J, Sánchez-Montero PE, Herrera FM, Córdova MS, Sánchez-Medal L.
    Arch Med Res; 1993 Jun 30; 24(1):23-6. PubMed ID: 8292873
    [Abstract] [Full Text] [Related]

  • 7. Implications of anticoagulants and gender on cell counts and growth factor concentration in platelet-rich plasma and platelet-rich gel supernatants from rabbits.
    González JC, López C, Carmona JU.
    Vet Comp Orthop Traumatol; 2016 Jun 30; 29(2):115-24. PubMed ID: 26786984
    [Abstract] [Full Text] [Related]

  • 8. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS, Rosborough D, Perkins H, Bolton T, Rock G, Ganz PR.
    Vox Sang; 1993 Jun 30; 65(4):258-70. PubMed ID: 8310678
    [Abstract] [Full Text] [Related]

  • 9. Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.
    Morgenthaler JJ, Zuber T, Friedli H.
    Vox Sang; 1985 Jun 30; 48(1):8-17. PubMed ID: 3918394
    [Abstract] [Full Text] [Related]

  • 10. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT, Snape TJ.
    Vox Sang; 1980 Jun 30; 38(4):222-8. PubMed ID: 6774480
    [Abstract] [Full Text] [Related]

  • 11. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K, Fuzimaki M.
    Nihon Rinsho; 1989 Dec 30; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract] [Full Text] [Related]

  • 12. The influence of anticoagulant on the in vitro level and stability of factor VIII procoagulant activity.
    Cumming AM, Wensley RT, Power DM, Delamore IW.
    Thromb Res; 1987 Apr 15; 46(2):391-5. PubMed ID: 3111005
    [No Abstract] [Full Text] [Related]

  • 13. The stability of factor VIII in heparinized plasma.
    Krachmalnicoff A, Thomas DP.
    Thromb Haemost; 1983 Jun 28; 49(3):224-7. PubMed ID: 6410534
    [Abstract] [Full Text] [Related]

  • 14. Effect of two anticoagulants on leukocyte yield and function, and on lysosomal enzyme activity.
    Branum E, Cummins L, Bartilson M, Hopper M, Pruett S, O'Brien JF.
    Clin Chem; 1988 Jan 28; 34(1):110-3. PubMed ID: 2892594
    [Abstract] [Full Text] [Related]

  • 15. FPA content - a criterion of quality for plasma as factor VIII source.
    Pflugshaupt R, Kurt G.
    Vox Sang; 1983 Jan 28; 45(3):224-32. PubMed ID: 6414185
    [Abstract] [Full Text] [Related]

  • 16. Improvement of plasma quality as raw material for factor VIII:C concentrates. Storage of whole blood and plasma and interindividual plasma levels of fibrinopeptide A.
    Carlebjörk G, Blombäck M, Akerblom O.
    Vox Sang; 1983 Jan 28; 45(3):233-42. PubMed ID: 6414186
    [Abstract] [Full Text] [Related]

  • 17. Effect of different anticoagulants on the labelling of red blood cells and plasma proteins with 99Tcm.
    Bernardo-Filho M, Gutfilen B, Maciel Ode S.
    Nucl Med Commun; 1994 Sep 28; 15(9):730-4. PubMed ID: 7816387
    [Abstract] [Full Text] [Related]

  • 18. [The study of anticoagulants selection in platelet-rich plasma preparation].
    Hua L, Lai G, Zhenjun L, Guie M.
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jul 28; 31(4):295-300. PubMed ID: 26665933
    [Abstract] [Full Text] [Related]

  • 19. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma.
    Blombäck M, Chmielewska J, Netré C, Akerblom O.
    Vox Sang; 1984 Jul 28; 47(5):335-42. PubMed ID: 6209855
    [Abstract] [Full Text] [Related]

  • 20. Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel.
    Giraldo CE, Álvarez ME, Carmona JU.
    BMC Vet Res; 2015 Mar 14; 11():60. PubMed ID: 25889052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.